Stuttering: Clinical Trials

2 trials for Stuttering, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow Stuttering: new trials by email Literature Review of Stuttering trials Research Report on Stuttering

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)
Ecopipam, Placebo - Childhood-Onset Fluency Disorder (Stuttering)
Phase 2CompletedEmalex Biosciences Inc.682020-10-222026-09-23
A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering
pagoclone, placebo - Stuttering
Phase 2 / Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company3212009-02-012012-08-28

Narrower conditions

Childhood-Onset Fluency Disorder (1)  ·  Communication Disorders (1)

Broader conditions

Language Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Speech Disorders (2)  ·  Communication Disorders (1)  ·  Mental Disorders (1)  ·  Neurodevelopmental Disorders (1)

Interventions

ecopipam (1)  ·  pagoclone (1)

Sponsors

Emalex Biosciences Inc. (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)

Countries

United States (2)

Top investigators

Atul R Mahableshwarkar, MD, DFAPA (1)